Treatment Of Hepatorenal Syndrome Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CPIX | F | Cumberland Pharmaceuticals Inc. | -1.56 | |
BIVI | F | BioVie Inc. | -4.17 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hepatorenal Syndrome stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
DFAC | B | Dimensional U.S. Core Equity 2 ETF | 0.0 | |
VTI | B | Vanguard Total Stock Market ETF | 0.0 | |
DFAT | C | Dimensional U.S. Targeted Value ETF | 0.0 | |
DFAS | C | Dimensional U.S. Small Cap ETF | 0.0 | |
DFUV | A | Dimensional US Marketwide Value ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
- Treatment Of Hepatorenal Syndrome
Treatment of hepatorenal syndrome (HRS) is aimed at improving kidney function and preventing further damage to the kidneys. Treatment options may include medications to reduce the amount of fluid in the body, medications to reduce the amount of toxins in the blood, and dialysis. In some cases, a liver transplant may be necessary.
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles